What we do
Neurocrine Biosciences is an American biopharmaceutical company, founded in 1992 and publicly traded on Nasdaq (NBIX), that discovers and develops treatments for neurological, endocrine, and psychiatric disorders. Its lead product, Ingrezza (valbenazine), received FDA approval in 2017 for tardive dyskinesia, and the company has an expanding pipeline covering conditions such as Parkinson's disease and congenital adrenal hyperplasia.
Why work here
Not added yet.
Locations
San Diego, CA
HeadquartersNo open roles at this location right now.
San Diego, CA
No open roles at this location right now.
Products
No products added yet.
Open positions
No open positions right now.
Connections here
Log in to see which of your connections work here.